Aspen Aerogels, Inc. — FY 2014 Form 10-K
Reporting period: Fiscal year ended December 31, 2014. The filing also reports fourth-quarter results. Financial amounts below are in U.S. dollars; annual figures are in millions unless stated otherwise.
Business context
Aspen designs and manufactures aerogel blanket insulation, primarily for energy infrastructure, and also performs contract research. Product revenue represented 97% of FY 2014 revenue; approximately 96% of product revenue was from energy-infrastructure applications. The company reported a 34% compound annual growth rate in product revenue since 2008 and an installed base exceeding 150 million square feet.
Financial performance and liquidity
| Metric | FY 2014 | FY 2013 |
|---|---|---|
| Total revenue | $102.4 | $86.1 |
| Product revenue | $99.3 | $82.1 |
| Gross profit | $17.1; 17% margin | $10.7; 12% margin |
| Operating loss | $(16.0) | $(20.0) |
| Net loss | $(66.3) | $(47.6) |
| Adjusted EBITDA (non-GAAP) | $3.0 | $(1.8) |
| Cash from operating activities | $6.6 | $(13.7) |
| Capital expenditures | $13.2 | $3.3 |
| Cash and cash equivalents, year-end | $49.7 | $1.6 |
| Working capital, year-end | $53.2 | $(3.4) |
| Total debt, year-end | $0.2, principally capital leases | $138.6 |
Product shipments rose 7% to 38.2 million square feet, while the average selling price increased 13% to $2.60 per square foot. Product cost of revenue declined to 84% of product revenue from 89%, reflecting improved yields, sourcing and manufacturing productivity. Research-services revenue fell 22% to $3.1 million.
Fourth-quarter 2014 revenue was $28.0 million, gross profit $5.2 million, operating loss $(2.7) million and net loss $(2.7) million. Compared with fourth-quarter 2013, revenue was $24.2 million, gross profit $3.6 million, operating loss $(6.6) million and net loss $(17.0) million.
Cash from operations improved substantially, but operating cash flow did not cover capital expenditures. The company ended the year with $49.7 million in cash, no revolving-credit borrowings, and $12.4 million of effective availability under its credit facility after letters of credit and borrowing-base limits. The facility’s stated maximum is $20 million.
Material changes and unusual items
- Revenue grew 19%, driven by product sales in petrochemical markets in North America, Asia and South America, and offshore oil projects. The year included $13.5 million in sales for a major Asian energy company’s petrochemical expansion and $5.9 million for Gulf of Mexico offshore projects.
- Net loss widened despite better operating results. FY 2014 included $50.3 million of interest expense, primarily fair-value accretion of convertible notes to their IPO conversion amounts. Management identified $38.8 million of IPO-related charges, including $33.2 million of note accretion and $5.6 million of performance-option compensation. The notes converted into common stock at the IPO; the large interest charge was primarily noncash.
- The June 2014 IPO generated $74.7 million in net proceeds. The company used $19.8 million to repay subordinated notes and revolving-credit borrowings; outstanding convertible debt converted into common shares. Year-end debt was reduced to $0.2 million.
- FY 2013 included a $3.4 million write-off of construction-in-progress assets after redesign and scaling back of the planned production line.
Outlook, risks and contingencies
- Management expected the third East Providence production line to begin operation in Q2 2015, adding 10–11 million square feet of annual nameplate capacity. Estimated total cost was $30.8 million; $22.7 million had been spent by year-end 2014.
- The company planned a second U.S. manufacturing facility, targeting initial production in 2017. Estimated cost for infrastructure and its first line was $80–$100 million, with 26–28 million square feet of annual nameplate capacity. Financing was expected to depend on operating cash flows, government grants, debt and potentially equity; funding was not assured.
- Management anticipated FY 2015 gross-margin improvement from pricing, yields, sourcing and product mix, partly offset by third-line start-up costs. It expected product costs to rise in dollars but decline as a percentage of product revenue. These are forward-looking expectations, not guaranteed results.
- Key risks include continued net losses and uncertain sustained cash generation; heavy capacity-investment needs; dependence on a single manufacturing site; execution and utilization risk for expansions; premium pricing and competition; exposure to energy-sector spending and lower oil and gas prices; raw-material supply and cost risks; customer concentration; and international currency, political, regulatory and compliance risks.
- Two customers accounted for 13% and 12% of FY 2014 revenue; the top ten represented approximately 60%. Three customers represented 17%, 17% and 11% of year-end receivables. Customer arrangements generally lacked long-term purchase commitments.
- The East Providence property has contamination from prior third-party activities subject to a deed restriction and soil-management plan. The filing reports no material legal proceedings and no probable or reasonably possible litigation loss requiring disclosure.
- Management reported significant deficiencies in financial reporting controls relating to staffing and income-tax controls, and described remediation actions. Disclosure controls were concluded effective; the company did not provide a management assessment of internal control over financial reporting because of the new-public-company transition period.
Important facts for investors to verify
- Whether the third production line commenced on schedule, reached expected yields and capacity, and stayed within its estimated cost.
- How the second-facility plan was financed, whether grants or debt were secured, and whether projected demand supports the planned capacity.
- Whether product pricing, mix, manufacturing efficiencies and gross margins continued to improve, particularly after the energy-sector downturn noted in the filing.
- Whether operating cash flow can fund working capital and planned capital expenditures without additional borrowing or equity issuance.
- Whether customer concentration, receivable exposure, control deficiencies and Section 382 limits on net operating losses changed after year-end.